Moderna (MRNA) Prepaid Assets (2017 - 2026)

Moderna (MRNA) has 10 years of Prepaid Assets data on file, last reported at $51.0 million in Q1 2026.

• On a quarterly basis, Prepaid Assets fell 91.28% year-over-year to $51.0 million in Q1 2026; TTM through Mar 2026 was $51.0 million, a 91.28% decrease from a year earlier, with the FY2025 full-year figure at $45.0 million, down 92.49% from the prior year.
• Prepaid Assets for Q1 2026 stood at $51.0 million, up from $45.0 million in the prior quarter.
• Over the last five years, Prepaid Assets for MRNA reached as high as $1.4 billion in Q1 2023 and fell as low as $31.0 million in Q2 2024.
• Historically, Prepaid Assets has averaged $442.9 million across 5 years, with a median of $76.0 million in 2022.
• Across the five-year window, Prepaid Assets surged 3661.11% in 2023 and plunged 97.4% in 2024, its largest moves.
• Year by year, Prepaid Assets stood at $1.2 billion in 2022, then sank by 92.64% to $88.0 million in 2023, then jumped by 580.68% to $599.0 million in 2024, then sank by 92.49% to $45.0 million in 2025, then advanced by 13.33% to $51.0 million in 2026.
• Per Business Quant data, the three most recent Prepaid Assets figures were $51.0 million in Q1 2026, $45.0 million in Q4 2025, and $56.0 million in Q3 2025.